|
|
(HealthNewsDigest.com) – Brand-name drug companies are fighting to weaken a provision of the health overhaul that was designed to open up generic competition in biotechnology medicines and save billions of dollars. – Lawmakers Struggle With pay-to-Delay
http://online.wsj.com/article/SB10001424052748703889204576078252260327210.html?mod=djemHL_t
Subscribe to our FREE Ezine and receive current Health News, be eligible for discounted products/services and coupons related to your Health. We publish 24/7.
HealthNewsDigest.com
For advertising/promotion, email: [email protected] Or call toll free: 877- 634-9180